Alkem Laboratories launches semaglutide in India at Rs 450 per week, eyes booming weight-loss market

Wait 5 sec.

Alkem Laboratories has launched a new semaglutide injection in India. This drug targets the growing diabetes and weight loss market. It is available under brand names like Semasize and Obesema. The injection is administered once weekly. Alkem offers a pre-filled pen for a month's dosage at Rs 1,800. This makes the weekly cost Rs 450.